Myelin oligodendrocyte glycoprotein: can it predict specific neurological conditions?

Lire cet article en français

High titers of antibodies against myelin oligodendrocyte glycoprotein (MOG) may help identify patients with certain neurological disorders, researcher say.

Previous studies have found associations between the presence of MOG antibodies (MOG-Ab) and numerous neurological disorders, such as neuromyelitis optica spectrum disorder (NMOSD) in adults and acute disseminated encephalomyelitis in children.

Ology Medical Education is a global provider of independent medical education. Its mission is to provide healthcare professionals with high-quality, trusted medical information with the aim of helping optimize patient care.

No responsibility is assumed by Ology Medical Education for any injury and/or damage to persons or property through negligence or otherwise, or from any use or operation of any methods, products, instructions, or ideas contained in the material herein. Because of rapid advances in the medical sciences, Ology Medical Education recommends that independent verification of diagnoses and drug dosages should be made. The opinions expressed do not reflect those of Ology Medical Education or the sponsor. Ology Medical Education assumes no liability for any material contained herein.